Astrazeneca (AZN) closed the most recent trading day at $94.23, moving +1.38% from the previous trading session. The stock ...
AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.
The AstraZeneca share price has risen to all-time highs over the past 12 months. Dr James Fox wishes he had more of the British pharma giant. The post Prediction: analysts think the AstraZeneca share ...
InvestorsHub on MSN
AstraZeneca plans NYSE move, ending Nasdaq ADS listing to simplify US share trading
AstraZeneca (NASDAQ:AZN) has announced it will shift its US listing from Nasdaq to the New York Stock Exchange, delisting its ...
Investing.com - Guggenheim has reiterated its Buy rating on AstraZeneca (NASDAQ:AZN) (AZN:LN) with a price target of ...
Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results